KRAS and colorectal carcinoma: Once again, this study is part of a more complex picture in which the KRAS mutation alone does not determine the eventual prognosis of patients affected by CRC, to which several factors contribute, including gender, age of the patient, staging of disease, and other molecular characteristics of tumors [32].